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Solution Structure of BID, an Intracellular
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While mitochondrial damage is the major amplification
step in the apoptotic pathway, the mitochondrion is also
the principal site of action for pro- and antiapoptoticSummary
members of the BCL2 superfamily. The BCL2 family of
proteins shares amino acid sequence homology in oneWe report the solution structure of BID, an intracellular
to four regions designated the BCL2 homology (BH)cross-talk agent that can amplify FAS/TNF apoptotic
domains: BH1, BH2, BH3, and BH4 (reviewed by Kelekarsignal through the mitochondria death pathway af-
and Thompson, 1998). The two well-known antiapo-ter Caspase 8 cleavage. BID contains eight a helices
ptotic members BCL2 and BCL-XL are usually localizedwhere two central hydrophobic helices are surrounded
on the cytoplasmic face of the mitochondrial outer mem-by six amphipathic ones. The fold resembles pore-
brane. Overexpression of BCL2 or BCL-XL blocks theforming bacterial toxins and shows similarity to BCL-
release of cytochrome c and aborts the apoptotic re-XL although sequence homology to BCL-XL is limited
sponse (Kluck et al., 1997; Yang et al., 1997). The survivalto the 16-residue BH3 domain. Furthermore, we mod-
function of BCL2 has also been implicated in its bindingeled a complex of BCL-XL and BID by aligning the BID to the CED4-like portion of Apaf1 to thereby prevent theand BAK BH3 motifs in the known BCL-XL±BAK BH3 activation of Procaspase 9 (Hu et al., 1998; Pan et al.,complex. Additionally, we show that the overall struc-
1998). In addition, both BCL2 and BCL-XL have beenture of BID is preserved after cleavage by Caspase 8.
shown to form selective ion channels in lipid membranesWe propose that BID has both BH3 domain±dependent
(Minn et al., 1997), which may regulate the mitochondrialand ±independent modes of action in inducing mito-
membrane potential and thus prevent cytochrome c re-chondrial damage.
lease. The proapoptotic members of the BCL2 family
include BAX, which contains multiple BH homology do-
mains (BH1, BH2, and BH3), as well as a class of mole-Introduction
cules sharing only the BH3 homology, such as BIK, BAD,
BID, and EGL1 (reviewed by Adams and Cory, 1998).The intracellular FAS signal transduction pathway of
The BH3 domain of the proapoptotic members of theapoptosis is initiated when Procaspase 8 is recruited
BCL2 superfamily has been shown to interact with anti-to the death-induced signaling complex (DISC) through
apoptotic members of the family (see review by Kelekarinteraction with the adapter molecule FADD/MORT1
and Thompson, 1998). Furthermore, the BH3 domains(Boldin et al., 1996; Muzio et al., 1996). The local aggre-
from proapoptotic, but not antiapoptotic, members ofgation of Procaspase 8 is sufficient to allow auto- or
the BCL2 family can induce the release of cytochrome ctransprocessing to produce active Caspase 8 (reviewed
from isolated mitochondria (Cosulich et al., 1997). Theseby Green, 1998; Muzio et al., 1998; Yang et al., 1998),
results suggest that the heterodimerization of pro- andwhich can subsequently activate executioners such as
antiapoptotic members of the BCL2 family may be criti-Caspases 3, 6, and 7. An alternative amplification path-
cal for killing induced by BAX-like molecules. Recently,way leading to large-scale activation of downstream
however, multiple lines of evidence suggest that pro-caspases is through mitochondrial damage. This path-
apoptotic functions of BAX-like molecules go beyond itsway is initiated upon cytochrome c release from mito-
ability to bind BCL2 or BCL-XL through the BH3 domains.chondria. Cytochrome c, in the presence of dATP, trig-
Genetic studies indicated that BCL2 and BAX function
gers the activation of Caspase 9 through Apaf1/Caspase
independently to regulate apoptosis in nonlymphoid cell
9 complex formation (Li et al., 1997). For the mitochon-
lineages as well as lymphoid cell lineages other than
dria pathway, Caspase 9 is the central initiator that acti-
thymocytes (Knudson and Korsmeyer, 1997). Mutagene-
vates the downstream executioners such as Caspases
sis of the BAX BH3 domain, which eliminated the ability
3, 6, and 7. Although activated Caspase 8 can lead of BAX to interact with BCL2 and BCL-XL, did not perturb
its ability to induce apoptosis (Wang et al., 1998). These
results suggest that BAX-like molecules have an impor-‖ To whom correspondence should be addressed (e-mail: wagner@
wagner.med.harvard.edu). tant mechanism of killing that is independent of the BH3
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domain, although the structural basis of this mechanism apoptosis independent of heterodimerization with BCL2
members, we propose that BID can induce mitochon-is unclear.
BID is a proapoptotic member of the BCL2 family drial damage through both BH3 domain±dependent and
±independent mechanisms.that shares only the BH3 domain homology with other
members of the family in its amino acid sequence. It has
recently been established as an intracellular messenger Results and Discussion
connecting the FAS receptor and the death-inducing
complex at the cytoplasmic membrane to the mitochon- Structure Determination
drial death machinery (Li et al., 1998; Luo et al., 1998). The structure of full-length BID was defined by a total
The full-length BID is inactive and present in the cyto- of 2202 NMR-derived distance constraints. For residues
solic fraction of living cells. Upon cleavage by Caspase 42±78, no long-range NOEs were observed. The local
8, the COOH-terminal part of BID then translocates to sequential NOE patterns and transverse 15N relaxation
mitochondria and is sufficient to trigger cytochrome c rates (data not shown) of this region are characteristic
release in isolated mitochondria. BID demonstrates of an unstructured and flexible loop. Interestingly, BCL-
some very unique and important properties after cleav- XL also has a long flexible loop (consisting of approxi-age by Caspase 8. In addition to the ability of truncated mately 64 residues) near the N terminus (Muchmore et
BID to translocate from cytosol to mitochondria, trun- al., 1996). In addition to residues 42±78, the N-terminal
cated BID has at least a 10-fold higher affinity toward 12 residues of BID, including Gly-1 and Ser-2 (which are
BCL-XL and is 100 times more efficient in inducing cyto- part of the thrombin cleavage site in the GST fusion
chrome c release from mitochondria compared to its protein), are not defined in the structure. However, this
full-length precursor (Li et al., 1998). Though BAX has is because the resonances of the amide protons of resi-
also been shown to induce cytochrome c release both dues 3±9 were not observed due to either fast amide
in vivo and in vitro (Jurgensmeier et al., 1998; Rosse proton exchange with solvent (at pH 7.0) or conforma-
et al., 1998), the cleaved BID is a much more potent tional exchange on an intermediate time scale. In all
cytochrome c±releasing factor than BAX (Luo et al., other regions, the structure is well determined. The en-
1998). Mutagenesis studies have also shown that trans- tire protein (including the loops) consists of 60% helices
location of truncated BID onto mitochondria is indepen- (Figure 1).
dent of its BH3 domain (Luo et al., 1998). Due to its Overall, the structure determination employed the
unique (or nonhomologous) sequence, BID has not been simple ªlocal to globalº strategy, which puts emphasis
related to any known structures other than its BH3 do- on stabilizing the local order prior to determination of
main. It remains to be a puzzle as to what conformational the global fold. This approach is very efficient, especially
feature of BID allows it to acquire so much more potency for solving structures of helical proteins (see Experimen-
in promoting cytochrome c release after Caspase 8 tal Procedures). First, the backbone NH resonances
cleavage. were rigorously confirmed by three pairs of triple-reso-
In this study, we have determined the solution struc- nance experiments, selective 15N labeling of Lys, Phe,
ture of BID using NMR spectroscopy. It consists of eight Ser, Tyr, Leu, Val, Ile, and Ala residues, and sequential
a helices arranged in a compact fold in resemblance to short-range NOEs. The 1H and 13C resonances of the side
transmembrane and pore-forming proteins of bacterial chains were determined by various TOCSY experiments.
toxins, such as diphtheria toxin and the colicins, sug- Second, helices were identified by both 13Ca chemical
gesting its potential to form selective ion channels on the shift values (Wishart and Sykes, 1994) and NH(i)±HA
mitochondrial membrane. Helices 6 and 7 are primarily (i 2 3) and NH(i)±NH(i 6 1) NOE patterns. Additionally,
hydrophobic and function as two central pillars, which using the short- and medium-range NOE patterns, some
are surrounded by six amphipathic helices. The struc- of the helix-turn-helix configurations were determined.
ture of BID shows striking similarity to BCL-XL despite The stabilization of local orders greatly reduced the con-
the fact that the amino acid sequences of these two formation search space. Finally, the global fold was de-
antagonists share only a 16-residue BH3 domain and termined by identifying key NOEs between hydrophobic
are otherwise unrelated. Based on a structure of BCL- side chains. This was confirmed by analyzing 3D 15N- and
XL±BAK BH3 peptide complex (Sattler et al., 1997) and 13C-dispersed NOESY and 2D homonuclear 1H NOESY
the position of the BH3 domain±containing helix in BID, experiments. Complete structural statistics and root-
we modeled the interaction between BCL-XL and the full- mean-square deviation values are presented in Table 1.
length BID. We also found that the four highly conserved The precision of this structure can also be assessed
hydrophobic residues of the BH3 domain that are re- from the dispersion of the 15 superimposed backbone
sponsible for heterodimerization are surface exposed
traces shown in Figure 2A.
in BID, suggesting their readiness to bind BCL-XL. Addi-
tionally, we monitored the conformation change in BID
Structure Overviewduring Caspase 8 cleavage and found that the overall
The three-dimensional structure of BID is illustrated instructural integrity of BID is preserved after it is cleaved.
Figure 2. Loops 1±12 and 43±77 are not displayed inAnalyzing 15N±1H cross peak changes upon cleavage,
the figure because they are completely disordered. Theconformational changes are localized and the role of
structured portion of BID consists of eight a helicesCaspase 8 cleavage in the dramatic enhancement of
arranged in a compact fold (Figures 2 and 5C). Theproapoptotic activity of BID is elucidated. Finally, based
primarily hydrophobic helices H6 and H7 are arrangedon structure comparison of BID and BCL-XL, along with
the recent finding that BID can promote mitochondrial in an antiparallel manner in the core of the protein. The
BID Structure and Apoptosis Regulation
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Figure 1. Amino Acid Sequences of BID and BCL-XL Aligned at the BH3 Domains (Shaded in Yellow)
There is no sequence homology between the two proteins outside the BH3 domain. Red and blue bars indicate helices identified in BID and
BCL-XL, respectively. The BH1 and BH2 domains of BCL-XL are shaded in light blue.
other six helices are amphipathic and packed around BID does not only function through heterodimerization
with BCL2. A mutant of the truncated BID, which cannotthe two central helices. Helix H3 contains the BH3 do-
main and is fixed by hydrophobic contacts with helix bind BCL-XL, can still target mitochondria and induce
apoptosis very efficiently (H. L. and J. Y., unpublishedH1 and helix H8. Structure comparison of BID and BCL-
XL (Figure 2C) shows extensive conformation homology results). In a separate study, Luo et al. showed that the
BH3 mutant of the truncated BID (G94E) associated withbetween the two proteins (Muchmore et al., 1996) al-
though their sequences are completely unrelated out- mitochondria to the same extent as the wild type (Luo
et al., 1998). On the other hand, heterodimerization mayside the 16-residue BH3 domain (Figure 1). The major
difference between the two structures is that BID has be important for the functions of BID. It has been pro-
posed that heterodimerization with other prosurvivalan extra helix (H2) in its N-terminal region. Additionally,
the flexible loop in BCL-XL between the BH3 domain± members of the BCL2 family is essential for the proapo-
ptotic activity of the BH3 members (reviewed in Adamscontaining helix (H2) and N-terminal helix (H1) is almost
twice as long as that in BID. By matching the structurally and Cory, 1998; Kelekar and Thompson, 1998). As the
BH3 domain is the only homologous region that BIDhomologous regions between these two molecules, we
found that H1, H3, H4, H5, H6, H7, and H8 of BID corre- shares with other members of the family, heterodimer-
ization would involve this domain. The above controver-spond to H1, H2, H3, H4, H5, H6, and H7 of BCL-XL,
respectively (Figure 1). sies may be resolved by the structural similarity between
BID and BCL-XL. Since the structure of BID is remarkablyThe surface electrostatic potential of BID shown in
Figure 3A does not reveal any unusually charged re- similar to BCL-XL, we propose that BID is able to interact
with mitochondria in a very similar way as to BCL-XLgions. However, BID has large hydrophobic patches on
the surface (Figure 3B). Since BID and BCL-XL are struc- and BAX, either by forming a selective ion channel or
interacting with some unknown receptors on the mem-turally similar, it is informative to compare their hy-
drophobic surfaces. Interestingly, four partially con- brane. BCL2 has been shown to bind the CED4-like
portion of Apaf1, dependent on its N-terminal BH4 do-served hydrophobic residues of the BH3 domain (I82,
I86, L90, and M97) are exposed in BID (Figures 1 and main (helix H1 in Figures 1 and 2C), and thereby prevent
the activation of Procaspase 9 (Hu et al., 1998; Pan et3B), whereas those of BCL-XL are buried (Figures 1 and
3C). As illustrated in Figure 3B, the surface of BID also al., 1998). Since the truncated BID does not have the
BH4 domain, one possible proapoptotic mechanism ishas a large hydrophobic cleft formed by L105, Y140,
V150, L151, and L154. This region remotely resembles that BID, upon cleavage by Caspase 8, can partially
mimic BCL-XL in interacting with mitochondria while notthe hydrophobic cleft (F105, L108, and L130) of BCL-
XL, which has been shown to bind BH3 death ligand inhibiting proapoptotic molecules such as Apaf1. In-
deed, this is in line with the previous finding, which was(Sattler et al., 1997). However, biological implication of
the BID hydrophobic cleft remains to be investigated. not well understood at the time, that cleavage of the
N-terminal BH4 domain of BCL2 by Caspase 3 can con-Thus far, neither BID homodimerization nor interaction
between BID and BH3 ligand has been reported. vert BCL2 into a proapoptosis protein (Cheng et al.,
1997). An equally possible mechanism would be that
the cleaved BID can target the mitochondrial membraneStructural Similarity to BCL-XL Implies
the Function of BID and form selective ion channels that counter the effect
of those formed by BCL-XL.Interaction between pro- and antiapoptotic members of
the BCL2 family has long been considered a crucial
mechanism for cell death induced by BAX-like members. Model for Heterodimerization between Full-Length
BID and BCL-XLHowever, multiple lines of recent evidence suggest that
proapoptotic activities of BAX-like proteins are indepen- As mentioned previously, one of the proapoptotic mech-
anisms adopted by BAX and BH3 proteins is to binddent of the heterodimerization via the BH3 domain (dis-
cussed in Introduction). Studies have also shown that BCL2 proteins and inhibit their antiapoptotic action via
Cell
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Figure 2. Solution Structure of BID
The flexible regions of BID (1±12 and 43±78) are not displayed.
(A) Stereoview of an ensemble of 15 out of 20 calculated structures representing the models with lowest energy (see Experimental Procedures).
Only backbone atoms (N, Ca, C9) are shown.
(B) Ribbons stereodrawing of BID showing the eight helices, labeled H1±H8. This view emphasizes the position of the BH3 domain±containing
H3 and the two hydrophobic helices H6 and H7.
(C) Ribbons drawings of BID (displayed in blue) and BCL-XL (displayed in brown) showing the comparison of the two structures. The coordinates
of BCL-XL were obtained from the Protein Data Bank with the ID code 1MAZ. The figure was generated with MOLMOL (Koradi et al., 1996).
their BH3 ªdeath ligands.º This heterodimerization can fashion. The structure of BCL-XL in complex with the
BH3 amphipathic helix of BAK revealed that the insertioneither prevent BCL2 from interacting with Apaf1 or affect
its ion channel formation on the mitochondria membrane of the BH3 helix of BAK into the hydrophobic cleft of
BCL-XL (formed by its BH1 and BH2 domains) is a keythat maintains the membrane potential (reviewed by
Adams and Cory, 1998; Kelekar and Thompson, 1998). event in the heterodimerization between death agonist
and antagonist (Sattler et al., 1997). According to theNow we know that BID and BAX members are structur-
ally related and should interact with BCL2 in a similar structure and mutagenesis studies (Sattler et al., 1997),
BID Structure and Apoptosis Regulation
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Figure 3. Surface Diagrams of BID and BCL-XL
The BCL-XL coordinates were obtained from the Protein Data Bank with ID code 1MAZ. In (A), the surface electrostatic potential is color
coded such that regions with electrostatic potentials ,28 kBT are red, while those .18 kBT are blue; kB and T are the Boltzmann constant
and temperature, respectively. In (B) and (C), surface-exposed hydrophobic residues, including Leu, Val, Ile, Met, Trp, Phe, and Tyr, are colored
in light green. (A) Electrostatic potential surface of BID, showing no distinct charged regions. (B) Hydrophobic surface of BID formed primarily
by residues in H6 and H3. (C) The elongated hydrophobic cleft of BCL-XL to which the BAK BH3 peptide binds. This cleft is formed primarily
by residues in H5 and H7. The figure was generated using GRASP (Nicholls et al., 1991).
four highly conserved hydrophobic side chains of the the binding surfaces of the two molecules complement
BAK BH3 helix point into the hydrophobic cleft of BCL- each other reasonably well (Figure 4B). The model
XL and stabilize complex formation. These four residues showed only minor stereochemical conflicts between
are V74, L78, I81, and I85, and they are aligned with resi- the two molecules that can be readily eliminated by
dues I86, L90, V93, and M97 of the BID BH3±containing slight outward movement of BID H3 during the docking
helix (H3), respectively (Figure 1). Based on the homol- process.
ogy model of BAK, derived from the structure of BCL-
XL, Sattler et al. found that the above four hydrophobic
residues of the BAK BH3 domain point toward the inte-
rior of the BAK protein, making these residues unavail-
able to interact with BCL-XL (Sattler et al., 1997). This
is expected, since the corresponding residues are also
buried in BCL-XL (Figure 3C), which was the structural
template for BAK modeling. As a result, the authors
suggested that binding to BCL-XL would necessitate a
conformational change near the BAK BH3 helix to ex-
pose the hydrophobic surface of that helix. Furthermore,
it was pointed out that such a conformational change
is facilitated by the presence of the highly flexible loop
preceding the BH3 helix.
Interestingly, residues I86, L90, V93, and M97 of the
BID BH3 domain are surface exposed and ready to bind
to a hydrophobic cleft. The surface representation of BID
(Figure 3B) shows that these residues form an elongated
hydrophobic patch on H3, adjacent to H8. Among these
four residues, V93 and M97 completely point outward,
whereas I86 and L90 are partially exposed and make
contact with the hydrophobic residues on H8 (Figure
4A). Based on the information from the BCL-XL±BAK
peptide complex (Sattler et al., 1997), it is likely that I86
and L90 of BID are released from H8 and turn completely
into the binding groove during heterodimerization. Addi-
tionally, the side chain of a highly conserved charged Figure 4. Model of the BID±BCL-XL Heterodimer
residue D95 (which corresponds to D83 of the BAK BH3 (A) Ribbon diagram showing the BH3 domain of BID and its environ-
domain) leans toward the BID interior, yet is partially ment. The surface-exposed side chains of four highly conserved
surface exposed. It is in a position to form a salt bridge hydrophobic residuesÐI86, L90, V93, and M97Ðand the charged
with R100 and possibly R103 of BCL-XL. This orientation residue D95 are displayed.
(B) Overall view of the model for the BID±BCL-XL heterodimer. Theis similar to that of D83 in the BCL-XL±BAK complex
docking was performed using the InsightII program (Biosym, Sanstructure. Since the BH3 helix of BID seems to be readily
Diego) by superimposing the BH3 domains of BAK and BID. Noteinserted into the hydrophobic cleft of BCL-XL, we tested that the red and blue BH3 helices of BAK and BID coincide almost
whether BID can be docked to BCL-XL without any ste- completely. The rotational orientation around the BH3-helix axis
reochemical conflict. By superimposing precisely the was achieved by superimposing the conserved residues of the BH3
BH3 helix of BID and that of BAK (in complex with BCL- domains. The coordinates of BCL-XL±BAK BH3 peptide complex
were obtained from the Protein Data Bank (ID code 1BXL).XL), we were able to obtain a heterodimer model in which
Cell
620
Figure 5. Monitoring the Conformation Change
in BID during Caspase 8 Cleavage
The proteolytic reaction is initiated by mixing
15N-labeled BID with unlabeled and active
Caspase 8 at the ratio of 100:1.
(A) SDS-PAGE showing the fraction of
cleaved BID. Four time pointsÐ0 min, 5 min,
20 min, and 4 hrÐwere recorded.
(B) 15N±1H HSQC spectrum of BID in the ab-
sence of Caspase 8 (control), BID after 20 min
of Caspase 8 reaction, and BID after 4 hr of
Caspase 8 reaction.
(C) Ribbon diagram of BID highlighting the
residues whose local chemical environments
are changed due to Caspase 8 cleavage. In
this representation, residues of which NH
chemical shift changes are greater than 0.1
and 0.02 ppm in 15N and 1H dimension, re-
spectively (based on the spectra shown in
[B]), are colored in red. Otherwise, they are
illustrated in gray.
Mechanism of BID Activation by Caspase 8 in Figure 5B are the times at which the individual experi-
ment was started. Since each 15N±1H HSQC experimentInasmuch as cleavage by Caspase 8 can greatly en-
hance the proapoptotic activity of BID, it has been hy- took 1 hr and 10 min, the line shapes of the cross peaks
that change upon cleavage are modulated in the spec-pothesized that such a dramatic activation is accompa-
nied by major conformation changes after cleavage. To trum started at 20 min. However, the spectrum recorded
after 4 hr represents the fully cleaved product. Interest-test this hypothesis, we monitored structural changes in
BID during Caspase 8 proteolytic reaction using 15N±1H ingly, the latter spectrum resembles very closely that of
BID in the absence of Caspase 8 (the control) (Figureheteronuclear single quantum coherence correlation
(HSQC) experiments (Bax et al., 1990; Cavanagh et al., 5B), suggesting that the overall structural integrity of
BID is preserved upon Caspase 8 cleavage. However,1996). The 15N±1H HSQC spectrum is characteristic of the
protein conformation and is thus sensitive to structural there are many small changes in resonance positions,
which are a result of minor conformation changes, andchanges. We initiated the proteolytic reaction by mixing
full-length BID and active Caspase 8 at the ratio of 100:1 can be easily traced in the spectra. Residues that
showed significant chemical shift changes are high-at room temperature. Then, 15N±1H HSQC spectra were
recorded after 20 min and 4 hr. The fraction of cleaved lighted in the ribbon drawing of BID (Figure 5C). As
expected, the changes predominantly occurred in theBID at these two time points can be assessed from
SDS-PAGE, shown in Figure 5A. The SDS-PAGE shows loop region near the cleavage site, the N-terminal helices
H1 and H2, H3 (containing the BH3 domain), H7, andalmost complete cleavage of BID after 4 hr of reaction
(Figure 5A). The times above the HSQC spectra shown H8. In the top view of the BID ribbon representation
BID Structure and Apoptosis Regulation
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shown in Figure 5C, it can be readily seen that H3, H7, element. If cleaved BID is initially associated with the
N-terminal domain, insertion of BH3 into the hydropho-and H8 all have close contacts with the N-terminal H1
and H2. Hence, small chemical shift changes are ex- bic cleft of BCL-XL could promote dissociation of H1
and H2. Thus, heterodimerization efficiency of the BH3pected for these regions due to small rearrangements
of H1 and H2 upon Caspase 8 cleavage. domain would depend on the local concentration of
BCL-XL and BID N-terminal domain. However, in full-The finding that the N-terminal domain remains intact
at approximately the same position and orientation length BID, the flexible loop can function as a chemical
cross-link that can oppose heterodimerization with BCL-shows that the loop between H3 and H2 has no tension
and plays no part in the folding of the eight helices in XL by maintaining a much higher local concentration of
the N-terminal domain.the uncleaved molecule. The unexpected result of this
study is that the uncleaved and cleaved BID have ap-
proximately the same conformation. On the other hand,
Conclusionthough the flexible loop is not important for the mainte-
We have determined the solution structure of BID, anance of BID structure, its cleavage has a profound
proapoptosis member of the BCL2 regulatory family thateffect on the proapoptotic activity. Upon cleavage, BID
has recently been established as a cross-talk agent forcan target mitochondria and induce apoptosis indepen-
relaying the FAS/TNF apoptotic signal to the mitochon-dent of its BH3 domain (H. L. and J. Y., unpublished
dria death pathway. It consists of eight a helices ar-results). Additionally, truncated BID can bind approxi-
ranged in a compact fold homologous to BCL-XL. Themately ten times stronger to BCL-XL via its BH3 domain
structure of BID also revealed that the BH3 domain±(Li et al., 1998). One possible mechanism for the activa-
containing helix is in a position ready for interaction withtion of BID is that the N-terminal segment may serve as
the hydrophobic cleft of BCL-XL that has been shown toan internal inhibitor of proapoptotic activity. We propose
bind the BAK BH3 domain. Using the available structuralthat the proapoptotic activity of BID requires dissocia-
data on the BCL-XL±BAK BH3 peptide complex, wetion of the N-terminal segment including H1 and H2.
modeled the heterodimerization between BCL-XL andWhile the N-terminal segment remains associated with
the full-length BID by superimposing the BH3 domainsthe core of BID at the high concentrations used for the
of BAK and BID. Since BID becomes truly active in pro-NMR experiment (Figure 5), at low cellular concentra-
moting cytochrome c release only after cleavage bytions of BID this segment may detach after Caspase
Caspase 8, we monitored the conformation change in8 cleavage and render the protein active. Even in the
BID during Caspase 8 reaction using NMR spectros-uncleaved BID, the N-terminal helices H1 and H2 may
copy. Analysis of the 15N±1H cross peaks of full-lengthtemporarily detach from the protein core, leading to
and cleaved BID concluded that the overall structuralsome (although much lower) activity of the uncleaved
integrity of BID is preserved after it is cleaved by Cas-protein.
pase 8. Additionally, based on the cleavage study, theThe effect of Caspase 8 cleavage should be discussed
role of Caspase 8 cleavage in the dramatic enhancementwith respect to the two models for the mechanism of
of proapoptotic activity of BID is elucidated. AlthoughBID function, formation of selective ion channels, like
the BH3 domain of BID is critical for its heterodimeriza-BCL-XL and BAX, and/or inhibition of the interaction of
tion with BCL-XL, truncated BID is capable of targetingBCL-XL with Apaf1. Channel formation by BID could be
mitochondria and promoting mitochondria damage in-promoted by Caspase 8 cleavage, since dissociation of
dependent of its BH3 domain (Luo et al., 1998; H. L.the N-terminal segment would expose the hydrophobic
and J. Y., unpublished results). In this study, we haveface of helices H6 and H7 (Figure 5C). The two helices
provided a structural basis for truncated BID±inducedresemble closely the two central pore-forming helices
mitochondrial damage. We propose that BID may haveH5 and H6 of BCL-XL (Minn et al., 1997; Matsuyama et
two modes of proapoptotic actions. First, BID can inter-al., 1998), which have been considered important for
act with proapoptotic members of the BCL2 familychannel formation. Figure 5C shows that dissociation
through their respective BH3 domains. We showed thatof the N-terminal H1 and H2 can expose the central
although the full-length BID can interact reasonably wellhydrophobic helices H6 and H7. Acquisition of channel-
with BCL-XL, cleavage by Caspase 8 and removal of H1formation capabilities after cleavage may be the switch
and H2 of BID may eliminate H1 as a competitive binderthat enables the molecule to vigorously target mitochon-
of the BH3 domain, making it more available for inter-dria and promote cytochrome c release. However, the
acting with BCL-XL. Second, BID also contains the struc-mechanism of cytochrome c release by pore formation
tural motifs for pore formation and is potentially able tois still unclear.
form selective ion channels similar to BAX and mayBID cleavage by Caspase 8 may also enhance hetero-
promote apoptosis in a way other than inhibiting BCL2dimerization with BCL-XL and prevent the formation of
proteins. Cleavage by Caspase 8 and dissociation of thethe antiapoptotic complex between BCL-XL and Apaf1.
N-terminal H1 and H2 expose the central hydrophobicDissociation of the N-terminal domain in BID is expected
helices H6 and H7, which remarkably resemble the twoto loosen the contact of H3 and H8 with the protein
central pore-forming helices H5 and H6 of BCL-XL (Minncore, and the H3 helix is less restricted to rearrange
et al., 1997; Matsuyama et al., 1998). The central hy-upon binding BCL-XL. The putative binding site for BCL-
drophobic helices H6 and H7 may be responsible forXL on helix H3 of BID and the contact area on H3 for
mitochondrial targeting after cleavage by Caspase 8 asthe N-terminal helix H1 are on opposite faces of this
H3 helix, and both interactions may have a competitive well as potential pore-forming ability of BID. Overall, we
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Table 1. Structural Statistics for the 15 Structures of Lowest Energy Obtained from 20 Starting Structuresa
NOE distance restraints
All 2202
Intraresidue 610
Interresidue 1592
Sequential (|i 2 j| 5 1) 760
Medium 287
i, i 1 2 63
i, i 1 3 150
i, i 1 4 74
Long (|i 2 j| .4) 405
Hydrogen bondsb 140
Dihedral angle restraints
φ (C9(i21) 2 Ni 2 Cai 2 C9i) 93
c (Ni 2 Cai 2 C9i 2 N(i11)) 94
x1 (Ni 2 Cai 2 Cbi 2 Cg1i or Og1i) 74
Ramachandrian plotc Residues 13±44, 77±197 Secondary Structure
Most favorable region 70.2 81.1
Additionally allowed region 21.7 15.4
Generously allowed region 7.3 3.3
Disallowed region 0.8 0.2
Average rms deviations from 0.044 6 0.001
experimental distance restraints (AÊ ) all (2102)
Average rms deviations from 0.32 6 0.04
experimental dihedral restraints (8) all (261)
Average rms deviations from
idealized covalent geometry
Bonds (AÊ ) 0.003 6 0.0001
Angles (8) 0.48 6 0.006
Impropers (8) 0.42 6 0.010
Average rms deviations of Residues 13±44, 77±197 Secondary Structure
atomic coordinates between 15 structuresd
Backbone (AÊ ) 0.92 0.54
Heavy atoms (AÊ ) 1.44 0.93
a None of these structures exhibited distance violations greater than 0.4 AÊ or dihedral angle violations greater than 58.
b During structure calculation, hydrogen bond restraints were added only for a helices, identified based on backbone 13Ca resonances (Wishart
and Sykes, 1994) and NH(I)±HA(I 2 3, I 2 4) NOE observed in the 3D 15N-NOESY-HSQC spectrum.
c The program PROCHECK nmr (Laskowski et al., 1993) was used to assess the quality of the structures.
d The precision of the atomic coordinates is defined as the average rms differences between the 15 final calculated structures and the mean
coordinates.
Experimental Procedurespropose that although there is only very limited se-
quence homology between BID and BAX, BID acts very
Expression and Purification of BIDsimilarly to BAX and may have multiple modes of action
Human full-length BID gene was amplified by PCR from EST cDNA
in inducing mitochondrial damage. clone 52055 using primers HL176 (59 CCGGATCCATGGACTGTGAG
The conformational similarity between BID and BCL- GTCAAC) and HL178 (59 GGGGATCCCTGAGTCAGTCCATCCCATTT
XL is rather surprising, since the two proteins are unre- CTG) and then cloned into the BamHI site of pGEX-2T vector. BID
was expressed in Escherichia coli with GST fused at the N terminus.lated in their amino acid sequences. This has been inde-
The transformed cells were grown in either LB-rich media (for unla-pendently shown by McDonnell et al. (1999 [this issue
beled protein) or M9-minimal media (for labeled protein). For isotopeof Cell]), who have solved the BID structure at 458C.
labeling, the M9 media were substituted with 15N-labeled ammoniaHowever, this phenomenon was also observed for pro-
(1 g l21) or 13C glucose (2 g l21). For triple-resonance experiments,
teins involved in caspase recruitment. The FAS death uniformly 15N, 13C, 2H-labeled protein was prepared by growing the
domain (DD), FADD death effector domain (DED), and cells in 90% D2O with 15N-labeled ammonia and 13C glucose. A 50%
caspase recruitment domain (CARD) are unrelated in deuterated and 15N, 13C-labeled sample was prepared by growing
the cells in 50% D2O with 15N ammonia and 13C glucose. For selectivesequence yet adopt the similar six-helix bundle confor-
amino acid labeling, the plasmid was transformed into DL39 cellmations (Huang et al., 1996; Chou et al., 1998; Eberstadt
line (cell that lacks aminotransferase) to minimize cross labelinget al., 1998). The recurrence of this phenomenon of dif-
between different amino acids. Selective 15N labeling was done by
ferent sequences yielding similar structures suggests growing the cells in M9 media supplemented with selected 15N-
that apoptosis is an ancient process that involves a labeled amino acids.
limited number of evolutionarily highly conserved struc- After cell lysis, the GST-fusion recombinant protein was first sepa-
rated from other E. coli proteins by GST affinity chromatography attural motifs. In order for them to construct an intricate
pH 7 and then cleaved off GST with thrombin (Biotech Pharmacia).network of regulatory pathways, a high degree of speci-
The eluted BID was purified to homogeneity using gel filtrationficity must be employed. For instance, BCL-XL, BID, and
(Sephadex G-50). The identity of the protein was confirmed byBAX are structurally similar yet functionally nonredun-
N-terminal sequencing, amino acid composition analysis, and SDS-
dant. Still, little is known about the detailed molecular PAGE. NMR samples contained 1 mM protein in 20 mM Tris (pH
mechanisms that allow them to take different roles in 7.0) and 5 mM NaCl in H2O/D2O (9/1) or D2O. For the homonuclear
NOESY experiment, the sample contained 1 mM protein in 50 mMapoptosis.
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NaPO4 (pH 7.0) in D2O. The NMR sample used for monitoring Cas- Bax, A., Ikura, M., Kay, L.E., and Torchia, D.A. (1990). Comparison
pase 8 cleavage was prepared by mixing 1 mM 15N-labeled BID with of different modes of two dimensional reverse correlation NMR for
unlabeled Caspase 8 at the ratio of 100:1. the study of proteins. J. Magn. Reson. 86, 304±318.
Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996).
NMR Spectroscopy Involvement of MACH, a novel MORT1/FADD-interacting protease,
All NMR spectra were acquired at 258C on Varian Unity 500, Varian in Fas/APO-1- and TNF receptor±induced cell death. Cell 85,
UnityPlus 500, Bruker 600, or Varian UnityPlus 750 spectrometers. 803±815.
For assignment of the backbone 1H, 13C, and 15N resonances, three
BruÈ nger, A.T. (1993). XPLOR Version 3.1 (New Haven, CT: Yale Uni-pairs of triple-resonance experiments were recorded using uniformly
versity Press).15N, 13C-labeled and 90% deuterated protein in H2O. These are [HNCA,
Cavanagh, J., Fairbrother, W.J., Palmer, A.G., III, and Skelton, N.J.HN(CO)CA], [HNCO, HN(CA)CO], and [HN(CA)CB, HN(COCA)CB] (for
(1996). Protein NMR Spectroscopy (San Diego, CA: Academicoverviews, see Clore and Gronenborn, 1993; Yamazaki et al., 1994;
Press).Matsuo et al., 1996a, 1996b). 13Cb decoupling was used in HNCA
and HN(CO)CA for higher 13Ca resolution and better signal sensitivity Cheng, E.H., Kirsch, D.G., Clem, R.J., Ravi, R., Kastan, M.B., Bedi,
(Matsuo et al., 1996b). In addition, amino acid±selective 15N labeling A., Ueno, K., and Hardwick, J.M. (1997). Conversion of Bcl-2 to a
of Lys, Phe, Ser, Tyr, Val, Leu, Ile, and Ala was used to confirm the Bax-like death effector by caspases. Science 278, 1966±1968.
sequential assignment of amide protons. Side-chain proton reso- Chou, J.J., Matsuo, H., Duan, H., and Wagner, G. (1998). Solution
nances were mostly assigned using 3D Cbd-HCCH-TOCSY (Clore
structure of the RAIDD CARD and model for CARD/CARD interaction
and Gronenborn, 1994; Matsuo et al., 1997) and 3D 15N-dispersed
in Caspase-2 and Caspase-9 recruitment. Cell 94, 171±180.
TOCSY-HSQC spectra, recorded using uniformly 15N, 13C-labeled
Clore, G.M., and Gronenborn, A.M. (1994). Multidimensional hetero-protein in D2O and uniformly 15N-labeled protein in H2O, respectively.
nuclear nuclear magnetic resonance of proteins. Methods Enzymol.The assignment of aromatic side chains was accomplished using
239, 349±363.homonuclear TOCSY and NOESY experiments, acquired with the
nonlabeled protein in D2O. Stereospecific assignment of methyl Cosulich, S.C., Worrall, V., Hedge, P.J., Green, S., and Clarke, P.R.
groups of Val and Leu residues was obtained from 13C-HSQC spec- (1997). Regulation of apoptosis by BH3 domains in a cell-free sys-
trum of a 10% 13C-labeled protein (Szyperski et al., 1992). Transverse tem. Curr. Biol. 7, 913±920.
15N relaxation rates were measured with experiments as described del Rio-Portilla, F., Blechta, V., and Freeman, R. (1994). Measure-
by Peng and Wagner (1992) and Farrow et al. (1994). ment of poorly-resolved splittings by J-doubling in the frequency
Distance restraints between amide protons and side chains were domain. J. Magn. Reson. A111, 132±135.
obtained from two 15N-dispersed NOESY spectra, acquired with
Dunbrack, R., and Karplus, M. (1993). Backbone-dependent rotamermixing times of 60 and 120 ms. Long-range distance restraints be-
library for proteins. Application to side-chain prediction. J. Mol. Biol.tween side chains (especially those of Val, Leu, and Ile) were ob-
230, 543±574.tained from a 13C-dispersed NOESY experiment with a mixing time
Eberstadt, M., Huang, B., Chen, Z., Meadows, R.P., Ng, S., Zheng,of 100 ms. NOE connectivities between aromatics and from aromat-
L., Lenardo, M.J., and Fesik, S.W. (1998). NMR structure and muta-ics to nonaromatic side chains were assigned with the combination
genesis of the FADD (Mort1) death-effector domain. Nature 392,of homonuclear 2D NOESY and 13C-dispersed NOESY spectra. NOE
941±945.distance restraints used for the structure calculations are summa-
rized in Table 1. Hydrogen bond distance restraints were imposed Farrow, N.A., Muhandiram, R., Singer, A.U., Pascal, S.M., Kay, C.M.,
only for the helical region, identified on the basis of 13Ca chemical Gish, G., Shoelson, S.E., Pawson, T., Forman-Kay, J.D., and Kay,
shift values (Wishart and Skyes, 1994) and NH(i)-HA(i 2 3, i 2 4) L.E. (1994). Backbone dynamics of a free and a phosphopeptide-
NOE cross peaks. The backbone torsion angles φ and c were ob- complexed Src homology 2 domain studied by 15N NMR relaxation.
tained using a method for measuring proton splitting in 15N-HSQC Biochemistry 33, 5984±6003.
spectrum by J doubling (del Rio-Portilla et al., 1994). The torsion Green, D.R. (1998). Apoptotic pathways: the roads to ruin. Cell 94,
angles x1 of side chains in helical regions were restrained within 695±698.
the ranges found in refined crystal structure using the rotamer librar-
Hu, Y., Benedict, M.A., Wu, D., Inohara, N., and Nunez, G. (1998). Bcl-ies of Dunbrack and Karplus (1993).
xL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9Structure calculations were performed following simulated an-
activation. Proc. Natl. Acad. Sci. USA. 95, 4386±4391.nealing protocols of Nilges et al. (1988) using X-PLOR 3.851 (BruÈ n-
Huang, B., Eberstadt, M., Olejniczak, E.T., Meadows, R.P., andger, 1993) on R10000 IndigoII Silicon Graphics work stations. Out
Fesik, S.W. (1996). NMR structure and mutagenesis of the FASof 20 starting structures, 19 had no violations larger than 0.4 AÊ or
(APO-1/CD95) death domain. Nature 384, 638±641.dihedral angle violations greater than 58. The 15 structures with the
lowest energy were selected for display (superimposed in Figure 2A). Jurgensmeier, J.M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D.,
Structures were displayed and analyzed using the InsightII program and Reed, J.C. (1998). Bax directly induces release of cytochrome
(Biosym, San Diego), GRASP (Nicholls et al., 1991), MOLMOL (Koradi c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 4997±
et al., 1996), and PROCHECK_nmr (Laskowski et al., 1993). The 5002.
structural statistics are presented in Table 1. Kelekar, A., and Thompson, C.B. (1998). Bcl-2-family proteins: the
role of the BH3 domain in apoptosis. Trends Cell Biol. 8, 324±329.
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